LENSAR Cataract Laser System Receives FDA Clearance for Corneal Incisions
LENSAR has announced its LENSAR Laser System has received FDA clearance for executing corneal incisions during cataract surgery, according to a news release.
LENSAR says the system is now FDA cleared for all the critical components of laser cataract surgery including lens fragmentation, anterior capsulotomy (with or without phacofragmentation) and corneal incisions.
"We are pleased with this latest broadening of the cleared indications for the LENSAR system as it demonstrates the continued ability of the LENSAR team to establish strategic development and commercialization objectives and then systematically deliver on those goals," said Nick Curtis, LENSAR's CEO, in the release. "At the same time, the continued expansion of FDA-cleared indications provides significant value to the cataract surgeon community and we expect this important regulatory milestone to add to the steadily increasing demand for our system worldwide."
LENSAR is headquartered in Orlando, Fla.
Related Articles on FDA Clearances:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About